News from NORD

Foundation Fighting Blindness Opens USH2A Natural History Study


 

The first patient has been enrolled in a four-year, 120-person study of the rate of disease progression and severity in people with mutations in the USH2A gene, a mutation that causes blindness and in some cases the loss of both vision and hearing. Additional information is available here.

Recommended Reading

Spinal CSF Leak Foundation and Cedars-Sinai Plan Intracranial Hypotension Symposium
Clinician Reviews
Vestibular Disorders Association Celebrates Balance Awareness Week
Clinician Reviews
Join the National Organization for Rare Disorders and the University of Massachusetts for Two Upcoming CME-Accredited Events
Clinician Reviews
Rare Disease Film Festival Is Planned
Clinician Reviews
NORD Outlines Recommendations for Health Care Reform in Letter to Congressional Leadership
Clinician Reviews
Alport Syndrome Research Funding Is Awarded
Clinician Reviews
Aplastic Anemia and MDS International Foundation Plans Regional Patient/Family Conference
Clinician Reviews
Global CMTC/OVM Conference to Take Place in The Netherlands
Clinician Reviews
Conan O’Brien to Host Congenital Hyperinsulinism International Event
Clinician Reviews
CurePSP International Research Symposium to Take Place in San Francisco
Clinician Reviews